Lithium 4,6-dichloropyridazine-3-carboxylate is a chemical compound that serves as a pharmaceutical intermediate. It is specifically used in the manufacturing process of deucravacitinib.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2245238-80-4
4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate
pharmaceutical intermediate
Methyl 4,6-dichloropyridazine-3-carboxylate
Pharmaceutical intermediate for deucravacitinib
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
Pharmaceutical intermediate for deucravacitinib
(2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone Phthalimido
Pharmaceutical impurity reference standard
(2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methanol hydrochloride
pharmaceutical intermediate
4-Amino-3-fluoropyridine
Pharmaceutical intermediate for BACE1 inhibitors
Py-MAA-Val-Cit-PAB-MMAE
antibody-drug conjugate linker payload
4,6-dichloropyridazine-3-carboxylic acid
pharmaceutical intermediate
lithium 4,6-dichloropyridazine-3-carboxylate
DAHURLFXBYFSFD-UHFFFAOYSA-M
[Li+].C1=C(C(=NN=C1Cl)C(=O)[O-])Cl
—